SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-21-007123
Filing Date
2021-02-05
Accepted
2021-02-05 16:51:49
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q f10q0620a1_180lifesciencesco.htm 10-Q/A 633842
2 CERTIFICATION f10q0620a1ex31-1_180lifesci.htm EX-31.1 10248
3 CERTIFICATION f10q0620a1ex31-2_180lifesci.htm EX-31.2 10308
4 CERTIFICATION f10q0620a1ex32-1_180lifesci.htm EX-32.1 5292
  Complete submission text file 0001213900-21-007123.txt   4521559

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE atnf-20200630.xml EX-101.INS 723518
6 XBRL SCHEMA FILE atnf-20200630.xsd EX-101.SCH 61938
7 XBRL CALCULATION FILE atnf-20200630_cal.xml EX-101.CAL 47047
8 XBRL DEFINITION FILE atnf-20200630_def.xml EX-101.DEF 222784
9 XBRL LABEL FILE atnf-20200630_lab.xml EX-101.LAB 345055
10 XBRL PRESENTATION FILE atnf-20200630_pre.xml EX-101.PRE 317564
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38105 | Film No.: 21596775
SIC: 2834 Pharmaceutical Preparations